Product Program year 2025 Source: CMS Open Payments

Accolade Sr

Device Accolade_Crm

PDI 00802526559150

Open in the dashboard

General payments

$690,894

8,550 payments

Research payments

$0

0 payments

Through program year 2025, $690,894 in general payments and $0 in research payments were reported against Accolade Sr (Accolade_Crm).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $619,180 5,404
2024 General $29,318 1,129
2023 General $25,139 1,093
2022 General $17,248 923
2021 General $8 1

Breakdown

Who paid General payments · program years 2021–2025
  1. Boston Scientific Corporation $690,894 8,550 payments
Top recipients General payments · program year 2025
  1. Richard Amaro New York, NY $71,052 11% · 2 payments
  2. Matthew Custodio Boston, MA $50,000 8% · 2 payments
  3. Jiun-Ruey Hu New Haven, CT $37,975 6% · 6 payments
  4. Ana Becerra Farmington, CT $20,000 3% · 1 payment
  5. Yousif Alsaiegh New York, NY $15,427 2% · 61 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Clinical Cardiac Electrophysiology Internal Medicine $35,244 18% · 359 practitioners
  2. Gastroenterology Internal Medicine $28,950 15% · 20 practitioners
  3. Cardiovascular Disease Internal Medicine $18,850 10% · 241 practitioners
  4. Internal Medicine $16,875 9% · 108 practitioners
  5. Interventional Cardiology Internal Medicine $16,480 9% · 93 practitioners

The top 5 of 102 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $137,039 22% · 193 recipients
  2. California $73,976 12% · 350 recipients
  3. Connecticut $69,670 11% · 18 recipients
  4. Massachusetts $58,126 9% · 53 recipients
  5. Texas $35,167 6% · 207 recipients

The top 5 of 52 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

8,550 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record